Horsetail Tea Trial Offers Hope for Rheumatic Disease Patients

A new study at the University Medical Center Freiburg is exploring whether horsetail tea could help patients with rheumatic diseases. Researchers are examining its effects on symptoms and inflammation in conditions like rheumatoid arthritis and lupus. The trial will track how well participants tolerate the tea over several weeks.

The study focuses on adults diagnosed with rheumatoid arthritis, spondyloarthritis, or systemic lupus erythematosus. To take part, patients must have a mildly active form of the disease and no planned changes to their current treatment.

Participants will drink 300 millilitres of horsetail tea each day for four weeks. They will continue their usual medication during this time. The trial runs for six weeks in total, with six appointments scheduled at the Center for Complementary Medicine in Freiburg.

Researchers aim to assess how well the tea is tolerated in daily life. They will also measure its impact on blood inflammation markers and existing symptoms. The number of participants recruited so far has not been made public.

The findings could provide insight into whether horsetail tea offers benefits for rheumatic disease patients. The study will run until all six weeks of data collection are complete. Results may help determine if further research into the tea's effects is warranted.